UNSPSC 51263155: Bucumolol hydrochloride

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H23NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U2Z7867QU7, chemically known as 5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy)coumarin hydrochloride, dl- but more generally known as bucumolol hydrochloride, which bears US NIH Compound Identifier 169786. European Medicines Agency schedules Bucumolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21960.

Most nations, for tariff and trade purposes, schedule bucumolol hydrochloride under HS 29322985. As of Q4 2014, BUCUMOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1CCC(C2C1CCC(=O)O2)OCC(CNC(C)(C)C)O.CL.

UNSPSC 51263155 Bucumolol hydrochloride is a Commodity code that shows little relevant recent activity tied directly to the pharmaceutical ingredient named in the code. The two most recent state and local opportunities tagged to this code involve naloxone procurement and a pharmacy benefit program restructuring—neither of which relates to bucumolol hydrochloride, a beta-blocker medication. Seminole County, Florida, through an IFB posted June 30, 2026, is soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county's Community Health Building; the Texas Health and Human Services Commission issued an RFI on April 3, 2026, to gather vendor intelligence on direct-to-manufacturer prescription programs for its pharmacy benefit system. Both opportunities represent legitimate state and local procurement activity, but neither targets the specific pharmaceutical substance this code nominally represents.

The mismatch between the code's scope and the recent opportunities suggests that either the opportunities were misclassified at tagging or that bucumolol hydrochloride sees minimal procurement activity through state and local channels. Practitioners evaluating this code should treat the recent postings as signals of limited commercial demand rather than genuine demand signals for the coded substance. If your firm supplies bucumolol hydrochloride to state and local health departments, county public health agencies, or state Medicaid programs, direct outreach to procurement offices in states with active pharmacy benefit procurement (Texas, Florida) may yield better positioning than tracking this code's activity.